Model
Edge
Scinai Immunotherapeutics Ltd
SCNI
Filing Type
F-3
Filing Date
5/7/2026
Updated
5/8/26, 2:01 PM
Copy Ref
Filing
F-3
Earnings Release
Exhibits
F-3
Registration Statement for Securities of Certain Foreign Private Issuers and Certain Canadian Issuers, Offered on a Continuous Basis
EX-4.5
FORM OF FINANCIAL ADVISOR WARRANT
EX-5.1
OPINION OF GOLDFARB GROSS SELIGMAN & CO., ISRAELI COUNSEL TO THE COMPANY
EX-23.1
CONSENT OF ZIV HAFT, CERTIFIED PUBLIC ACCOUNTANTS IN ISRAEL AND A MEMBER OF BDO, INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
EX-23.2
CONSENT OF YARON ROTEM, CPA, CERTIFIED PUBLIC ACCOUNTANT
EX-FILING FEES
FILING FEE TABLE
GRAPHIC
Graphic
GRAPHIC
Graphic